LUMOS PHARMA INC

CUSIP: 55028X109 Class: COM

Lion Point Capital, LP's Holding History (CIK: 0001643354)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 39,589 Value ($000) $153 Avg Close Range
Q2 2024
Shares 90,794 Value ($000) $211 Avg Close Range
Q1 2024
Shares 90,794 Value ($000) $256 Avg Close Range
Q4 2023
Shares 90,794 Value ($000) $289 Avg Close Range
Q3 2023
Shares 90,794 Value ($000) $300 Avg Close Range
Q2 2023
Shares 78,351 Value ($000) $259 Avg Close Range
Q1 2023
Shares 51,205 Value ($000) $169 Avg Close Range
Q4 2022
Shares 51,205 Value ($000) $732 Avg Close Range
Q3 2022
Shares 51,205 Value ($000) $732 Avg Close Range
Q2 2022
Shares 51,205 Value ($000) $732 Avg Close Range
Q1 2022
Shares 51,205 Value ($000) $481 Avg Close Range
Q4 2021
Shares 51,205 Value ($000) $354 Avg Close Range
Q3 2021
Shares 407,192 Value ($000) $3,872 Avg Close Range
Q2 2021
Shares 407,192 Value ($000) $4,071 Avg Close Range
Q1 2021
Shares 407,192 Value ($000) $4,764 Avg Close Range
Q4 2020
Shares 407,192 Value ($000) $14,540 Avg Close Range
Q3 2020
Shares 407,192 Value ($000) $5,627 Avg Close Range
Q2 2020
Shares 407,192 Value ($000) $6,714 Avg Close Range
Q1 2020
Shares 407,192 Value ($000) $3,461 Avg Close Range